Company Name : Glaxo Smith Kline ISIN Code : EGS38171C012 Reuters Code : BIOC.CA Content : The Listing Committee held on 26/06/2024 decided to obligate the company to provide EGX with a shareholders structure for the period ending on 30/09/2023, 31/12/2023 & 31/03/2024 and obligate the company to provide EGX with the steps that has taken to eliminate and correct violations in addition to present the violations to the company's first Board of Directors within 7 days.